The American Journal of Managed Care1h
Tildrakizumab Effective Up to Nearly 3 Years Regardless of BSA Affected, Obesity
Posters presented at the 2025 American Academy of Dermatology Annual Meeting found tildrakizumab outcomes to have a mean drug ...